Folic acid-modified bovine serum albumin targeted delivery of curcumin induces ferroptosis and apoptosis in glioma cells
Purpose This study aims to construct a folate-modified bovine serum albumin (BSA) nanocarrier for targeted curcumin(Cur) delivery to glioma cells and evaluate its anti-glioma efficacy via ferroptosis and apoptosis pathways. Methods Folate-BSA-curcumin nanoparticles (Cur@BSA-FA) were prepared by the desolvation method. Physicochemical characterization included particle size, Zeta potential, Fourier-transform infrared spectroscopy, transmission electron microscopy, drug loading, and in vitro release. Anti-glioma activity was assessed in C6 glioma cells using the cell counting kit-8, wound healing, colony formation, reactive oxygen species (ROS), malondialdehyde (MDA), lipid hydroperoxide (LPO), iron levels, apoptosis, glutathione peroxidase 4 (GPX4), and Bcl-2 protein expression. In vivo efficacy was evaluated in subcutaneous xenograft models. Results Cur@BSA-FA exhibited a favorable particle size (122.4 nm), negative Zeta potential, sustained release profile, and high drug loading. The nanoparticles significantly inhibited cell proliferation, wound closure, and colony formation in a dose-dependent manner. Mechanistically, Cur@BSA-FA elevated ROS, MDA, LPO, and iron levels while downregulating GPX4 and Bcl-2, indicating synergistic ferroptosis and apoptosis. In vivo , the nanosystem significantly suppressed tumor growth with good biosafety. Conclusions Cur@BSA-FA mediates targeted delivery at least partially via folate receptor-mediated endocytosis and induces both ferroptosis and apoptosis in C6 glioma cells, suggesting a potential nanotherapeutic strategy that warrants further evaluation in orthotopic glioma models.
Authors
- 毛雅迪
- Yu Qian (ORCID: https://orcid.org/0000-0003-2338-5831)
- Wei Peng (ORCID: https://orcid.org/0009-0000-6038-0349)
- Chao Huang
- Lixia Yang (ORCID: https://orcid.org/0009-0002-7917-7302)
Institutions
- Shaoxing University (CN)
- Shaoxing People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.3389/fonc.2026.1968983
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00